Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
15 employees · est. 2018 · New Haven, United States
Synthekine
Synthekine a biotechnology company focused on discovery and developing best in class cytokine therapeutics
62 employees · est. 2018 · Menlo Park, United States
Synthekine is the larger of the two.
Side-by-Side Comparison
| Metric | Simcha Therapeutics | Synthekine |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2018 |
| Headquarters | ||
| Headquarters | New Haven, United States | Menlo Park, United States |
| Employees | ||
| Employees | 15 | 62 larger |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series B | Series C |
| Total Funding | ||
| Total Funding | $65.00M | $289.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 3 |
| Services | ||
| Services | Not tracked yet | Research and Development of Cytokine Therapeutics, Cytokine Partial Agonists, Surrogate Cytokine Agonists |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer Patients, Patients with Autoimmune Diseases, Healthcare Providers, Pharmaceutical Partners |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Immunobiology, Cytokine Therapeutics, Engineered Cytokines, Oncology, Clinical-stage, Immunotherapy, Cancer Treatment, Precision Medicine, Biological Challenges, Immune System Modulation, Clinical Trials, Solid Tumors, Immune-biology, Disease-modifying Therapy | Cytokine Therapeutics, Immunotherapy, Cancer Treatment, Autoimmune Disorders, Protein Engineering, Cytokine Partial Agonism, Immunological Specificity, Preclinical Studies, Safety And Efficacy, Targeted Protein Engineering, Modified Cytokines, Cytokine-enhanced Cell Therapies, Surrogate Cytokine Agonists, Inflammatory Disease Treatment |
| Website | ||
| Website | simchatx.com | synthekine.com |
About Simcha Therapeutics
Simcha Therapeutics is a clinical-stage biotechnology startup founded in 2018 and headquartered in the United States. The company's slogan "Overcoming biological challenges in clinically translatable pathways" reflects its focus on pioneering first-in-class engineered cytokine therapeutics. Their le...
About Synthekine
Synthekine, founded in 2018, is a biotechnology company headquartered in the United States, focused on engineered cytokine therapeutics for cancer and autoimmune disorders. By leveraging immunological insights and targeted protein engineering, Synthekine aims to discover and develop groundbreaking t...
We will tell you when either one moves
BounceWatch watches Simcha Therapeutics and Synthekine for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Simcha Therapeutics and Synthekine — by email.
Frequently Asked Questions
Compare Simcha Therapeutics with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Simcha Therapeutics on 12 Sep 2024, and Synthekine on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.